Vimarsana
Biggest News Aggregation in the World

Immunologicals Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunologicals Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunologicals Ltd Today - Breaking & Trending Today

Indian Immunologicals Launches First Indigenously Developed Hepatitis A Vaccine, 'Havisure' - Vimarsana News

Indian Immunologicals Launches First Indigenously Developed Hepatitis A Vaccine, 'Havisure'

Hepatitis A, a viral infection primarily spreads through the fecal-oral route, meaning it is transmitted through the ingestion of contaminated food or water

Source: ndtv.com
Indian Immunologicals introduces indigenously developed Hepatitis A vaccine - Vimarsana News

Indian Immunologicals introduces indigenously developed Hepatitis A vaccine

Havisure is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose.

Global Animal Biotechnology Market Size/Share Envisaged to Reach USD 56,949.40 Million By 2032, at 8.8% CAGR: Polaris Market Research - Vimarsana News

Global Animal Biotechnology Market Size/Share Envisaged to Reach USD 56,949.40 Million By 2032, at 8.8% CAGR: Polaris Market Research

/PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled "Animal Biotechnology Market Share, Size, Trends, Industry Analysis...

Veterinary Vaccine Market Size to Reach USD 13,681.4 Million in 2030 - Vimarsana News

Veterinary Vaccine Market Size to Reach USD 13,681.4 Million in 2030

/PRNewswire/ -- The veterinary vaccine market size reached USD 7,975.3 Million in 2021 and is expected to register a CAGR of 6.2% during the forecast period,...

IIL to set up animal vaccine facility in Hyderabad's Genome Valley - Vimarsana News

IIL to set up animal vaccine facility in Hyderabad's Genome Valley

Indian Immunologicals Ltd (IIL) on Monday announced that it will invest Rs 700 crore to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad.